By Issam

Drew Weissman is a University of Pennsylvania immunologist who was awarded the Nobel Prize in Physiology or Medicine for his pioneering research on messenger RNA. He has been involved in developing vaccines against COVID-19 and other diseases.

Biography:  https://medicalxpress.com/news/2023-10-nobel-winning-mrna-weissman-defeat-covid.html

34%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a poor reputation for journalistic standards and is not considered a reliable news source.

Bias

10%

Examples:

  • The article mentions that lixisenatide is a drug used to treat diabetes without specifying that it belongs to a class of drugs called GLP-1 receptor agonists, which are also being explored for their potential neuroprotective effects. This omission may create confusion or misleading impressions about the nature and purpose of lixisenatide.
  • The article quotes only one source from each university who participated in the study, without providing any other perspectives or counterarguments. This may give a biased impression that there is more consensus than there actually is among experts on the validity and implications of the results.

Conflicts of Interest

50%

Examples:

  • The article mentions gastro side effects of nausea, vomiting and reflux without disclosing any other potential risks or negative impacts associated with this drug on Parkinson's disease patients.

Contradictions

100%

Examples:

  • The article mentions gastro side effects of nausea, vomiting and reflux without disclosing any other potential risks or negative impacts associated with this drug on Parkinson's disease patients.
  • The author claims that this study marks clear results and demonstrates an impact on slowing down symptoms but fails to mention that these effects were noticeable only by professionals who made patients do tasks such as walking, standing up, moving their hands etc.
  • The title of the article suggests that a diabetes drug has shown promise against Parkinson's disease when in fact it only slowed down the progression of motor issues associated with Parkinson's disease.

Deceptions

30%

Examples:

  • The article mentions gastro side effects of nausea, vomiting and reflux without disclosing any other potential risks or negative impacts associated with this drug on Parkinson's disease patients.
  • The author claims that this study marks clear results and demonstrates an impact on slowing down symptoms but fails to mention that these effects were noticeable only by professionals who made patients do tasks such as walking, standing up, moving their hands etc.
  • The title of the article suggests that a diabetes drug has shown promise against Parkinson's disease when in fact it only slowed down the progression of motor issues associated with Parkinson's disease.

Recent Articles

Lixisenatide Promising in Slowing Parkinson's Disease Progression, Study Finds

Lixisenatide Promising in Slowing Parkinson's Disease Progression, Study Finds

Broke On: Friday, 05 April 2024 A diabetes drug has shown promise in slowing the progression of symptoms associated with Parkinson's disease, according to a new study published in The New England Journal of Medicine. Lixisenatide, which is similar to drugs such as Ozempic and Wegovy, slowed the progression of motor disability in patients with early-stage Parkinson's disease after 12 months.